Jacobs Levy Equity Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.31M | Sell |
|
|||||
|
2025
Q1 | $13.7M | Sell |
|
|||||
|
2024
Q4 | $59.9M | Buy |
|
|||||
|
2024
Q3 | $42.6M | Sell |
|
|||||
|
2024
Q2 | $66.4M | Buy |
|
|||||
|
2024
Q1 | $37.9M | Buy |
|
|||||
|
2023
Q4 | $10.3M | Sell |
|
|||||
|
2023
Q3 | $9.59M | Sell |
|
|||||
|
2023
Q2 | $14.9M | Buy |
|
|||||
|
2023
Q1 | $7.77M | Buy |
|
|||||
|
2022
Q4 | $1.23M | Sell |
|
|||||
|
2022
Q3 | $58.4M | Sell |
|
|||||
|
2022
Q2 | $147M | Sell |
|
|||||
|
2022
Q1 | $147M | Buy |
|
|||||
|
2021
Q4 | $144M | Buy |
|
|||||
|
2021
Q3 | $110M | Sell |
|
|||||
|
2021
Q2 | $149M | Buy |
|
|||||
|
2021
Q1 | $123M | Buy |
|
|||||
|
2020
Q4 | $108M | Buy |
|
|||||
|
2020
Q3 | $87.6M | Buy |
|
|||||
|
2020
Q2 | $106M | Buy |
|
|||||
|
2020
Q1 | $97.3M | Sell |
|
|||||
|
2019
Q4 | $104M | Buy |
|
|||||
|
2019
Q3 | $71M | Buy |
|
|||||
|
2019
Q2 | $26.2M | Buy |
|
|||||
|
2019
Q1 | $13.9M | Buy |
|
|||||
|
2018
Q4 | $1.53M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $9.96M | Sell |
|
|||||
|
2017
Q2 | $22.1M | Sell |
|
|||||
|
2017
Q1 | $37.3M | Sell |
|
|||||
|
2016
Q4 | $41M | Sell |
|
|||||
|
2016
Q3 | $53.5M | Buy |
|
|||||
|
2016
Q2 | $43.2M | Sell |
|
|||||
|
2016
Q1 | $50.1M | Sell |
|
|||||
|
2015
Q4 | $62M | Sell |
|
|||||
|
2015
Q3 | $61.3M | Sell |
|
|||||
|
2015
Q2 | $73.7M | Sell |
|
|||||
|
2015
Q1 | $72.6M | Buy |
|
|||||
|
2014
Q4 | $68.9M | Buy |
|
|||||
|
2014
Q3 | $60.2M | Buy |
|